Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self‐supervised deep learning
Cancer Medicine · 2024
DOI: 10.1002/cam4.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Qingyuan Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Von Hippel-Lindau Tumor Suppressor Protein, Kidney Neoplasms, Deep Learning, Mutation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Province Central Guiding Local Science and Technology Development Project, Hubei Province Key Research and Development Project.
Abstract (Originalsprache)
Background
Tumor mutation burden (TMB) and VHL mutation play a crucial role in the management of patients with clear cell renal cell carcinoma (ccRCC), such as guiding adjuvant chemotherapy and improving clinical outcomes. However, the time‐consuming and expensive high‐throughput sequencing methods severely limit their clinical applicability. Predicting intratumoral heterogeneity poses significant challenges in biology and clinical settings. Our aimed to develop a self‐supervised attention‐based multiple instance learning (SSL‐ABMIL) model to predict TMB and VHL mutation status from hematoxylin and eosin‐stained histopathological images.
Methods
We obtained whole slide images (WSIs) and somatic mutation data of 350 ccRCC patients from The Cancer Genome Atlas for developing SSL‐ABMIL model. In parallel, 163 ccRCC patients from Clinical Proteomic Tumor Analysis Consortium cohort was used as independent external validation set. We systematically compared three different models (Wang‐ABMIL, Ciga‐ABMIL, and ImageNet‐MIL) for their ability to predict TMB and VHL alterations.
Results
We first identified two groups of populations with high‐ and low‐TMB (cut‐off point = 0.9). In two independent cohorts, the Wang‐ABMIL model achieved the highest performance with decent generalization performance (AUROC = 0.83 ± 0.02 and 0.8 ± 0.04 in predicting TMB and VHL, respectively). Attention heatmaps revealed that the Wang‐ABMIL model paid the highest attention to tumor regions in high‐TMB patients, while in VHL mutation prediction, non‐tumor regions were also assigned high attention, particularly the stromal regions infiltrated by lymphocytes.
Conclusions
Our results indicated that SSL‐ABMIL can effectively extract histological features for predicting TMB and VHL mutation, demonstrating promising results in linking tumor morphology and molecular biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Centre for Reproductive Science, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Trusted Computing and Information Assurance Laboratory, Institute of Software, Chinese Academy of Sciences, Beijing, China.
- Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Qingyuan Zheng, Xiuheng Liu, Zhiyuan Chen
Förderung
- Hubei Province Central Guiding Local Science and Technology Development Project
- Hubei Province Key Research and Development Project
Zitieren
APA
Zheng, Q., Wang, X., Yang, R., Fan, J., Yuan, J., Liu, X., Wang, L., Xiao, Z., & Chen, Z. (2024). Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self‐supervised deep learning. Cancer Medicine. https://doi.org/10.1002/cam4.70112
Vancouver
Zheng Q, Wang X, Yang R, Fan J, Yuan J, Liu X, et al. Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self‐supervised deep learning. Cancer Medicine. 2024. doi:10.1002/cam4.70112
BibTeX
@article{Zheng2024,
author = {Zheng, Qingyuan and Wang, Xinyu and Yang, Rui and Fan, Junjie and Yuan, Jingping and Liu, Xiuheng and Wang, Lei and Xiao, Zhuoni and Chen, Zhiyuan},
title = {Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self‐supervised deep learning},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70112}
}
EUVIMED